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a b s t r a c t
The effects of feed solution pH and membrane orientation on water ﬂux and the rejection of carbamazepine and sulfamethoxazole were investigated using a bench scale forward osmosis (FO) system. Water
ﬂux was pH-dependent in both membrane orientations. In addition, water ﬂux increased while the speciﬁc reverse salt ﬂux and hydrogen ion ﬂux decreased with increasing feed solution pH. Water ﬂux was
lower in the normal FO mode compared to that in the pressure retarded osmosis (PRO) mode because
osmotic pressure differential was reduced due to the internal concentration polarisation (ICP) phenomenon. The rejection of neutral carbamazepine was generally pH independent in both membrane orientations. The rejection of carbamazepine in the PRO mode was lower than that in the FO mode due to the
higher concentration gradient caused by concentrative ICP in porous supporting layer. Steric hindrance
was probably the main separation mechanism for the neutral carbamazepine in the FO process. On the
other hand, the rejection of sulfamethoxazole was signiﬁcantly affected by the feed solution pH in both
membrane orientations. Variation in the rejection sulfamethoxazole could be attributed to the electrostatic repulsion between the negatively charged FO membrane surface and varying effective charge of
the sulfamethoxazole molecule.
Crown Copyright Ó 2012 Published by Elsevier B.V. All rights reserved.

1. Introduction
The last two decades have seen the shortage of drinking water
supply further exacerbated due to population growth, irregular
weather patterns as a result of climate change, and environmental
contamination [1,2]. At the same time, trace organic contaminants
of anthropogenic origin have also emerged. These trace organic
contaminants have been frequently detected at trace level ranging
from a few nanogram per litre (ng/L) to several microgram per litre
(lg/L) in sewage, efﬂuent from sewage treatment plants, water
bodies, and in some cases, even drinking water [3–6]. Some of
these contaminants are pharmaceutically active or can potentially
induce a range of adverse endocrine disrupting effects on vertebrates at environmentally relevant concentrations (i.e., several
ng/L). Not surprisingly, many dedicated studies have been focused
on the use of advanced water treatment technologies for effective
removal these trace organic contaminants, thus allowing for the
utilisation of non-conventional water sources such as treated efﬂuent. Around the world, a number of water reclamation facilities
have been built to provide a supplementary source of water supply
[7,8]. In many countries including the USA, Singapore, and several
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European states, water recycling has been shown to be a successful
strategy to ensure the replenishment of catchment or reservoir for
potable water supply and reduce dependency on sources vulnerable to climate change [1,8,9]. Examples of advanced treatment
technologies widely used in water recycling applications to ensure
sufﬁcient removal of trace organic contaminants include nanoﬁltration or reverse osmosis, and ultraviolet radiation [8,10].
Although these advanced treatment processes demonstrate efﬁcient removal of a wide range of trace organic contaminants from
impaired water resources, they can be energy intensive. As a result,
several new treatment technologies have been proposed and
investigated in recent years.
Forward osmosis (FO) is one such emerging water treatment
technology. FO utilises an osmotic pressure differential to drive
the permeation of clean water across the membrane into the draw
solution [11]. FO is highly attractive for water treatment due to its
low fouling propensity [12], simple conﬁguration, and low energy
consumption [13,14]. Consequently, a number of investigations
have focused on the use of FO in wastewater treatment. The effectiveness of FO has been demonstrated by the treatment of landﬁll
leachate [15], anaerobic digester concentrate [16], activated sludge
solution [17,18], and domestic wastewater [19]. In most cases, FO
is used as an advanced pre-treatment technique in conjunction
with a draw solution recovery process, such as reverse osmosis
(RO) and membrane distillation (MD). In a recent study, Cath
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et al. [20] proposed such a hybrid FO–RO system to combine
wastewater reclamation and seawater desalination. In this hybrid
system, treated efﬂuent with low osmotic pressure (low salinity)
is ﬁrst treated by an FO membrane and clean water is drawn into
a seawater draw solution. The diluted draw solution is subsequently desalinated by RO to produce fresh water suitable for beneﬁcial uses. In another study, Wang et al. [21] demonstrated a
hybrid FO–MD system to treat highly viscous protein solution
where FO is employed for dewatering protein solutions while MD
is used for draw solution recovery. These hybrid systems are capable of providing a dual-barrier treatment against trace organic contaminants and largely reducing the treatment burden of
downstream processes. In addition, because FO has very low fouling propensity, these hybrid systems can be used to treat feed
water of low quality. Hancock et al. [22] recently conducted a life
cycle assessment exercise to compare the environmental impact
of the FO–RO dual-barrier concept and RO technology for seawater
desalination application. They reported that, if the full technical
potential of FO technology can be realised, the environment impact
of an FO–RO hybrid system is 25% less than that of the current
state-of-the-art RO process [22]. It is noteworthy that a draw solution recovery process is not required in all cases. When the draw
solute can add value to the extracted water, the diluted draw solution can be directly consumed without any further treatment [23].
Examples of these applications include several FO water puriﬁcation products (such as X-pack, Life Pack, Expedition, and HydroWell) that are commercially available from Hydration Technology
Innovations (www.htiwater.com) and even the extraction of water
from urine for direct consumption by astronauts during their space
mission [24]. In these applications, it is essential that trace organic
contaminants are effectively removed by the FO process.
Little is known about the removal behaviours of trace organic
contaminants during the FO process. Cartinella et al. [25] demonstrated that FO can completely remove the steroid hormones estrone and estradiol. Cath et al. [20] investigated the removal of
diclofenac, gemﬁbrozil, naproxen and salicylic acid by an FO membrane and reported rejection values of 99%, 80%, 90% and 72%,
respectively. Similar rejection of 13 trace organic contaminants
by FO membrane was observed as well [26]. Hancock et al. [27] revealed signiﬁcant variation in the rejection of trace organic contaminants by the FO process in the range from 40% (tris-(2carboxyethyl)-phosphine (TCEP)) to more than 95% (sulfamethoxazole) when they examined the separation of 30 compounds using
a bench scale FO system. Given the similarity between the molecular weight of TCEP (250 g/mol) and sulfamethoxazole (253 g/
mol), the underlying reasons for their signiﬁcantly different rejection behaviours remain largely unknown. In addition, because
mass transfer in the FO process is driven exclusively by a chemical
concentration gradient, the transport mechanisms of the FO and
pressure driven ﬁltration processes such as NF and RO may not
be the same. In fact, Xie et al. [28] has demonstrated that at the
same permeate ﬂux, rejection of some hydrophobic trace organics
under the FO mode was higher than that under the RO mode. The
authors attributed this observation to the retarded forward diffusion phenomenon that could occur in the FO process at high draw
solute ﬂux.
The FO membrane can be operated in two different conﬁgurations, namely the normal FO mode and pressure retarded osmosis
(PRO) mode. The former refers to a conﬁguration in which the active layer of the FO membrane is placed against the feed solution,
while the latter refers to a conﬁguration in which the active layer
of the FO membrane is placed against the draw solution. Jin et al.
[29] through a modelling study showed that the boron ﬂux in
the PRO mode was higher than that in the FO mode. Mi and Elimelech [30] experimentally demonstrated that membrane fouling
was more severe in the PRO mode than that in the FO mode. Tang

et al. [31] have subsequently reported similar observations. However, there remains a lack of systematic and mechanistic understanding of the rejection of trace organic contaminants by FO in
the two membrane orientations. Such understanding is essential
for further development of the FO technology, especially when it
is used to purify water contaminated with trace organics.
In this study, we examined the water ﬂux behaviour and rejection of two PhACs – namely sulfamethoxazole and carbamazepine
– by an FO membrane. The water ﬂux, reverse salt ﬂux, and hydrogen ion ﬂux were systematically related to the surface charge and
hydrophobicity of the membrane at different feed solution pH and
two membrane orientations. Experimental results were analysed
to elucidate the effects of solution pH and membrane orientation
on water ﬂux and PhACs rejection, thus providing further insight
into the rejection mechanisms of trace organic contaminants by
FO membrane.
2. Materials and methods
2.1. FO membrane
An asymmetric FO membrane acquired from Hydration Technology Innovations (HTI, Albany, OR) was used in this investigation. According to the manufacturer, the operational pH range of
this membrane is from pH 3.5 to 7.5. This membrane exhibited
comparably lower water permeability and higher salt rejection
than a typical commercial NF membrane. Although the actual composition of the membrane is proprietary information, it has been
suggested that the membrane has a dense cellulose-based active
layer embedded in polyester mesh providing mechanical support.
A detailed description of the membrane is provided elsewhere [11].
2.2. Laboratory scale FO system
FO experiments were conducted using a closed-loop benchscale ﬂat plate FO membrane system (Supplementary Data,
Fig. S1). The membrane cell was made of acrylic plastic. The dimensions of the channels were 13 cm long, 9.5 cm wide, and 0.2 cm
deep. The total effective membrane area for mass transfer was
123.5 cm2.
Two variable speed gear pumps (Micropump, Vancouver, WA)
were used to circulate the feed and draw solutions. Flow rates of
the feed and draw solution ﬂow were monitored using two rotameters and kept constant at 1 L/min (corresponding to a cross ﬂow
velocity of 9 cm/s). The draw solution reservoir was placed on a
digital balance (Mettler Toledo Inc., Hightstown, NJ) and weight
changes were recorded by a computer to calculate the permeate
ﬂux. The conductivity of the draw solution was continuously measured using a cell constant of K = 1 cm1 conductivity probe (ColeParmer, Vernon Hills, Illinois). To maintain constant draw solution
concentration, a peristaltic pump was regulated by a conductivity
controller to intermittently dose a small volume of a high concentration draw solution (6 M) into the draw solution reservoir (control accuracy ±0.1 mS/cm). The concentrated draw solution
makeup reservoir was also placed on the same digital balance.
The transfer of liquid between the two reservoirs did not interfere
with the measurement of permeate ﬂux and the system could be
operated with a constant osmotic pressure.
2.3. Experimental protocol
The feed was prepared by spiking carbamazepine and sulfamethoxazole (Sigma–Aldrich, Saint Louis, MO) into a background
electrolyte solution (20 mM NaCl and 1 mM NaHCO3) to generate
a concentration of 250 lg/L. These background electrolytes were
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selected to simulate the typical composition in the treated secondary efﬂuent and to maintain the constant pH of the feed solution
[32,33]. Either HCl (1 M) or NaOH (1 M) was used to adjust the
pH value of the feed solution. Analytical grade NaCl (Fisher
Scientiﬁc, Pittsburgh, PA) was used to prepare the draw solution
in Milli-Q water. The volumes of the feed solution and draw solution were 4 and 1 L, respectively. Temperatures of the feed and
draw solutions were kept constant at 23 ± 0.1 °C using a temperature control unit (Thermo Fisher Scientiﬁc, Waltham, MA) in all
experiments. Both FO and PRO mode experiments were conducted.
In the FO mode experiments, the active layer of the FO membrane
was placed against the feed solution, and in the PRO mode experiments, the active layer of the FO membrane was placed against the
draw solution. A new FO membrane sample was used for each
experiment. Approximately 1 mL of samples from both the feed
tank and draw solution tank were taken at speciﬁc intervals for
HPLC analysis.

2.4. Contact angle measurement
Contact angle measurements were conducted using a RameHart Goniometer (Model 250, Rame-Hart, Netcong, NJ) and employed a standard sessile drop method. FO membrane samples
were submerged into a pH-adjusted electrolyte background solution (20 mM NaCl and 1 mM NaHCO3) ranging from pH 3.5 to 7.5
for 10 h. After removing excess liquid, the membrane samples
were ﬁxed onto a glass slide using double-sided adhesive tape
and then dried in a desiccator for at least 24 h prior to contact angle measurements. pH-adjusted Milli-Q water was used as the reference solvent for the corresponding pH-adjusted membrane
sample. Ten water droplets were used on each membrane sample
and contact angles on both sides of the droplet were analysed.

2.7. Analytical methods
A Shimadzu HPLC system (Shimadzu, Kyoto, Japan) equipped
with a Supelco Drug Discovery C-18 column (with diameter,
length, and pore size of 4.6 mm, 300 mm, and 5 lm, respectively)
and a UV–vis detector was used to measure the concentrations of
the sulfamethoxazole and carbamazepine in the feed and draw
solutions. The detection wavelength was 280 nm and sample injection volume was 50 lL [36]. The mobile phase composed of acetonitrile and Milli-Q grade deionised water buffered with 25 mM
KH2PO4. Two eluents, namely, eluent A (80% acetonitrile + 20% buffer, v/v) and eluent B (20% acetonitrile + 80% buffer, v/v) were
delivered at 1.0 mL/min through the column in time-dependent
gradient proportions for 20 min. The detailed eluent gradient time
program is provided in the Supplementary Data, Table S1. Calibration generally yielded standard curves with coefﬁcients of determination (R2) greater than 0.99 within the range of experimental
concentrations used. The analysis was carried out immediately
upon the conclusion of each experiment. A sample injection volume of 50 lL was used considering the salt tolerance of C18 column. The quantiﬁcation limit for all the analytes under
investigation using these conditions was approximately 10 lg/L.
Conductivity and pH of the feed and draw solutions were measured using an Orion 4-Star Plus pH/conductivity metre (Thermo
Fisher Scientiﬁc, Waltham, MA).
2.8. Rejection calculation
In a typical FO process, the permeate concentration of target
solute is diluted by the draw solution. Therefore, the apparent concentration of the target solute in the draw solution overestimates
the actual rejection performance. To evaluate the real performance
of the FO process, the actual (corrected) concentration of the target
solute, Cs(t) can be recalculated by taking the dilution into account
using mass balance:

2.5. Zeta potential measurement
The zeta potential of the membrane surface was determined
using a SurPASS electrokinetic analyser (Anton Paar GmbH, Graz,
Austria). The zeta potential of each membrane surface was calculated from the measured streaming potential using the Fairbrother-Mastin approach. All streaming potential measurements were
conducted in a background electrolyte solution containing
10 mM KCl. Hydrochloric acid and potassium hydroxide were used
to adjust pH by means of automatic titration. The test solution was
used to ﬂush the cell thoroughly prior to the pH adjustment for
each measurement. All streaming potential measurements were
performed at room temperature (approximately 22 °C), which
was monitored by the temperature probe of the instrument.

2.6. Representative PhACs
Two pharmaceuticals, namely sulfamethoxazole and carbamazepine, were selected for this study. Their key physicochemical
properties together with molecular structures are presented in
Table 1. Sulfamethoxazole and carbamazepine are frequently detected in secondary treated efﬂuent, sewage affected water bodies,
and recycled water for non-potable purposes (see for example:
[34,35]). They represent two different drug categories. Sulfamethoxazole is a frequently used antibiotic while carbamazepine is a
widely used anti-epileptic drug. These compounds were purchased
from Sigma–Aldrich (St. Louis, MO) and their reported purities
were 99% or higher. The pharmaceuticals were ﬁrst dissolved in
pure methanol to make up stock solutions of 1 g/L. The stock solutions were stored at 18 °C and were used within one month.

109

C sðtÞ ¼

C dsðtÞ V dsðtÞ  C dsðt1Þ V dsðt1Þ
V wðtÞ

ð1Þ

where Vw(t) is the permeate volume of water to the draw solution at
time t, Vds(t-1) is the volume of draw solution at time (t-1), Vds(t) is
the volume of draw solution at time t, Cds(t) is the measured concentration of target solute in the draw solution at time t, and Cds(t-1) is
the measured concentration of target solute in the draw solution at
time (t-1). Subsequently, the solute rejection in the FO process is
calculated using the actual (corrected) permeate concentration,
yielding:



C sðtÞ
100%
RFO ¼ 1 
C fðtÞ

ð2Þ

where Cf(t) is the concentration of the target solute in the feed at t
time.
3. Results and discussion
3.1. Flux behaviour
3.1.1. Permeate water ﬂux
The asymmetric membrane can be operated in two different
orientations, namely FO and PRO modes. The water ﬂux obtained
from the PRO mode was considerably higher than that in the FO
mode (Fig. 1). This difference in water ﬂux is due to the internal
concentration polarisation (ICP) phenomenon which has been described in detail in several previous studies [37,38]. ICP occurs
when the solute concentration within the membrane supporting
layer differs from that of the bulk solution. In the FO mode, the
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Table 1
Key physicochemical properties of PhACs used in this study.
Pharmaceutical

Carbamazepine

Table 2
Contact angle of the active and supporting layers of the FO membrane at different pH
values (mean ± standard deviation of ten repeated measurements).

Sulfamethoxazole

Structure

Molecular weight (Da)
pKaa
Log Kowa
Dipole moment (Debye)b
Stokes radius (nm)
Molecular length (nm)b
Molecular width (nm)b
Molecular depth (nm)b

236.3
9.73
2.45
3.6
0.37
0.891
0.529
0.507

253.3
1.7, 5.8
0.89
5.4
0.38
1.031
0.587
0.526

a

From the SciFinder Scholar (ACS) database.
Molecular dimension and the dipole moment were calculated using Molecular
Modelling Pro Version 6.3.3 (Chem SW Inc.).

draw solution inside the porous supporting layer becomes diluted
as water permeates from the feed through the active layer into the
protective conﬁnes of the membrane supporting structure. In the
PRO mode, the feed solute is concentrated within the porous supporting layer, thus reducing the overall osmotic gradient across the
membrane. McCutcheon and Elimelech [38] referred to these two
phenomena as dilutive and concentrative ICP, respectively. Because the osmotic pressure of the feed solution was much smaller
than that of the draw solution, the dilutive ICP in the FO mode is
more pronounced than concentrative ICP in the PRO mode, which
substantially reduces the effective osmotic driving force for water
ﬂux. While the ICP phenomenon may not impact the osmotic pressure at the feed side in the PRO mode, it can lead to the build-up of
PhACs within the supporting layer of the membrane at the feed
side, thus inﬂuencing the rejection of the PhACs. Effects of the
ICP phenomenon on the rejection of sulfamethoxazole and carbamazepine will be discussed in detail in section 3.2.
Water ﬂux was a function of the feed solution pH in both orientations (Fig. 1). The water ﬂux increased by 27.6% and 7.5% in the
FO and PRO modes, respectively, as the feed solution pH increased

2

Average Flux (L/m h)

Active layer (°)

Supporting layer (°)

3.5
4.5
5.5
6.5
7.5

70.9 ± 3.1
66.7 ± 3.6
64.8 ± 2.9
62.8 ± 3.9
60.2 ± 3.4

79.7 ± 1.0
75.0 ± 3.2
70.8 ± 3.2
71.1 ± 1.8
69.7 ± 3.4

from 3.5 to 7.5. This behaviour may be attributed to conformational changes of the cross-linked membrane polymer structure
and changes in the membrane hydrophobicity as a function of
the solution pH. These two possible mechanisms can be elucidated
by membrane surface charge characteristics, especially the zeta
potential proﬁles of the active layer (Fig. 1a) and supporting layer
(Fig. 1b) as well as the hydrophobicity (Table 2) of the FO
membrane. It is hypothesised that the electrostatic repulsion between ionisable functional groups of the membrane polymeric matrix increases as the solution pH increase, thereby leading to an
increased average pore size and higher permeate ﬂux. Indeed, the
zeta potential of both the active layer and the supporting layer
became more negatively charged with increasing feed solution
pH. The results reported in Fig. 1 are also in good agreement with
the pH-dependent water ﬂux response in some nanoﬁltration
processes [39,40]. It is also noted that the FO membrane surface
becomes more hydrophilic through dissociation of carboxyl
functional groups (COO) of the active layer as the solution pH
increased (Table 2). A more hydrophilic membrane could favour
water transport. In fact, this hypothesis is consistent with the
correlation between hydrophobicity of FO membrane and water
ﬂux observed by McCutcheon and Elimelech [41].

b

9

pH

3.1.2. Reverse salt ﬂux and hydrogen ion ﬂux
The speciﬁc reverse salt ﬂux (Js/Jw) is a quantitative indicator for
bi-directional diffusion in the FO process. Higher speciﬁc reverse
salt ﬂux reﬂects a decrease in the selectivity of the membrane

8

(a)

6
Zeta potential of active layer
Average flux in FO mode
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4
2
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6
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7

Zeta potential (mV)

110
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2
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(b)
8

-4

Zeta potential of supporting layer
Average flux in PRO mode

-6

7

Zeta potential (mV)

4

2

Average Flux (L/m h)
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-8
3
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5

pH (-)
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8

Fig. 1. The water ﬂux as a function of feed pH in FO and PRO modes. Experimental conditions were: 1 M NaCl as draw solution, the cross ﬂow rate was 1 L/min for both sides,
and the cross ﬂow velocity was 9 cm/s. The temperature of both sides was kept at 23 ± 0.1 °C. Zeta potential of active and supporting layer of the HTI FO membrane was
measured with background electrolyte of 1 mM KCl. The error bar represents the standard deviation from duplicate experiments.
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3.2. Rejection of PhACs
3.2.1. General behaviour
The feed solution pH and membrane orientation play key roles
in the rejection of carbamazepine and sulfamethoxazole. The rejection proﬁle of carbamazepine is relatively pH-independent, while
that of sulfamethoxazole is strongly pH-dependent within the pH
range of this study. The stable rejection of carbamazepine
(Fig. 4a) can be ascribed to its neutral form in the pH range
investigated here. In contrast, feed solution pH had a considerable
effect on the rejection of sulfamethoxazole (Fig. 4b). At near neutral pH values (pH 6.5 and 7.5), the rejection of sulfamethoxazole
was above 90 % and constant throughout the experiment.
However, at acidic pH values (i.e., pH 3.5, 4.5, and 5.5), the rejection of sulfamethoxazole was low and decreased gradually over
the ﬁrst few hours of experiment. This pH-dependence behaviour
resulted from the speciation of sulfamethoxazole (pKa of
sulfamethoxazole = 5.8), from a neutral species at high pH to a
negatively charged one at lower pH [45,46]. The initial and gradual
decrease in sulfamethoxazole rejection at low pH observed in Fig. 4
may be attributed to the hydrogen ion ﬂux from the feed to the
draw solution (Fig. 3) which may result in a higher localised pH
immediately at the membrane surface. Further investigation is
required to fully substantiate this phenomenon.
Membrane orientation had a direct impact on the rejection proﬁles of the two compounds. The rejection of carbamazepine was

Water flux
Reverse salt flux

(a) FO mode
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8
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(b) PRO mode
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and the lower efﬁciency of the process [42]. In both the FO and PRO
modes, the speciﬁc reverse salt ﬂux decreased with increasing feed
solution pH (Fig. 2). This implies that better selectivity and efﬁciency are expected with a basic feed solution rather than that with
an acidic one. This decrease in the speciﬁc reverse salt ﬂux is
mostly driven by the increase in water ﬂux. The water ﬂux
increases signiﬁcantly at higher pH whilst the salt ﬂux is suppressed by the more negatively charged FO membrane.
The pH of the feed solution consistently increased during the
course of each experiment (Fig. 3). Due to the feed volume reduction during the FO process, the measured changes in the feed pH
during the experiment may not reﬂect the transport of hydrogen
ion. Thus, the molar ﬂux of hydrogen ion out of the feed solution
is used to describe the hydrogen ion transport. Similar feed pH variation was also observed by Hancock et al. [42] and Phuntsho et al.
[43]. This pH variation can be explained by charge neutrality and
concentration gradient driven diffusion. Hydrogen ion diffuses
through the FO membrane to maintain feed solution electroneutrality when sodium permeates into the feed side. Therefore,
higher speciﬁc reverse salt ﬂux in the FO mode (Fig. 2) leads to
the higher hydrogen ion ﬂux. In addition, according to Fick’s law,
the hydrogen ion ﬂux is directly proportional to the difference in
ion concentrations across the membrane [44]. The hydrogen ion
concentration gradient decreases with increasing feed pH, and thus
a decreased hydrogen ion ﬂux is expected as observed in this
study.

320
8.0

Feed pH (-)

Fig. 2. Permeate of hydrogen ion ﬂux from the feed as a function of initial feed pH in FO and PRO modes. Hydrogen ion ﬂux was calculated based on the pH change of the feed
at the end of a 10-hour experiment. The draw solution (1 M NaCl) pH was 6.25.
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Hydrogen ion flux (mmol/(m h))
Fig. 3. Water, reverse salt (NaCl) and speciﬁc reverse salt ﬂuxes in the FO and PRO modes at different feed pH values. The experimental conditions were described as in Fig. 1.

more than 50% of sulfamethoxazole was removed in the FO mode
(Fig. 4b), but only 20% rejection of sulfamethoxazole was found for
the PRO mode (Fig. 5b).
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Fig. 4. The rejection of (a) carbamazepine, and (b) sulfamethoxazole as a function of
time at different feed pH in FO mode (concentration of carbamazepine and
sulfamethoxazole = 250 lg/L in the feed, the background electrolyte contained
20 mM NaCl and 1 mM NaHCO3, draw solution = 1 M NaCl; cross ﬂow velocity on
either sides of the membrane = 9 cm/s; feed and draw solution temperature = 23 ± 0.1 °C). The error bar represents the standard deviation from duplicate
experiments.

approximately 90% in the FO mode (Fig. 4a), while a rejection of
only 70% was obtained in the PRO mode (Fig. 5a). The rejection
behaviour of sulfamethoxazole was also notably different in the
two membrane orientations. At unfavourable acidic pH values,

3.2.2. Effect of solution pH
The feed pH appears to be a major parameter governing the
rejection of sulfamethoxazole in the FO process. Results presented
in Fig. 6a are consistent with the behaviour of sulfamethoxazole
during nanoﬁltration processes [45] and may be attributed to a
combination of the speciation of the compound, membrane surface
charge, and feed solution pH. Carbamazepine, with pKa value of
9.73, is a neutral compound in the investigated pH range of 3.5
to 7.5. Thus, steric hindrance (and not electrostatic interaction) is
the dominant rejection mechanism for carbamazepine. This
hypothesis is supported by the constant rejection value of carbamazepine of approximately 90% regardless of the feed solution pH. It
is noteworthy that rejection of the neutral sulfamethoxazole (at pH
3.5 and 4.5) is lower than carbamazepine (Figs. 4 and 5) while the
molecular weight of sulfamethoxazole is comparable to that of carbamazepine (Table 1). This different rejection behaviour may be
due to the dipole moment and molecular shape of these two
compounds. In the absence of electrostatic interaction, sulfamethoxazole facilitated with a high dipole-ﬁxed charge interaction is
more likely to be attracted to the membrane pores [47]. In addition, sulfamethoxazole is cylindrical in shape with large molecular
length and small molecular width and depth (Table 1). Nghiem
et al. [46] have also reported lower rejection of the neutral
sulfamethoxazole compared to that of carbamazepine by an NF
ﬁltration process.
On the other hand, sulfamethoxazole can dissociate from a neutral species to a negatively charged anion as the feed pH becomes
increasingly more acidic below its pKa value of 5.8. The active layer
of the membrane becomes more negatively charged with increasing feed pH [30]. Hence, the rejection mechanism is controlled
by both steric hindrance and electrostatic repulsion between the
negatively charged active layer of FO membrane and anionic sulfamethoxazole. These interactions result in a near complete rejection
of sulfamethoxazole at pH values beyond its pKa. It is interesting to
note that the sigmoidal rejection curve of sulfamethoxazole as a
function of feed pH resembles the shape of its speciation
(Fig. 6c). This further suggests that electrostatic repulsion is a sig-
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Fig. 5. The rejection of (a) carbamazepine, and (b) sulfamethoxazole as a function of
time at different feed pH in PRO mode (experimental conditions were as per Fig. 4).
The error bar represents the standard deviation from duplicate experiments.

niﬁcant governing mechanism in the separation of sulfamethoxazole by FO membrane.
3.2.3. Effect of membrane orientation
Membrane orientation can exert some impact on the rejection
of carbamazepine and sulfamethoxazole during the FO process.
For the neutral compound carbamazepine, the rejection in the FO
mode was 20% higher than that in the PRO mode (Fig. 6). The different rejection behaviour of carbamazepine in the FO and PRO
modes is attributed to the ICP effect. Because the ICP phenomenon
may not signiﬁcantly impact the osmotic pressure gradient in the
PRO mode, the effective mass transfer driving force in the PRO
mode is higher than that in the FO mode. In addition, in the PRO
mode, carbamazepine is subjected to the concentrative ICP within
the porous supporting layer of the membrane [29] leading to a
higher concentration gradient across the dense active layer of the
membrane. Therefore, the ICP phenomenon can negatively affect
the rejection of carbamazepine in a similar fashion to that caused
by the normal concentration polarisation phenomenon. At pH 3.5
and 4.5, the rejection of sulfamethoxazole in the PRO mode was
lower than that in the FO mode, but with the increase of feed solution pH, the rejection of sulfamethoxazole increased with insignificant difference in sulfamethoxazole rejection between the two
membrane orientations. It is noted that the supporting layer of
the membrane was more negatively charged than the active layer
when the pH was above 5.5 (Fig. 1). Thus, the rejection of sulfamethoxazole was enhanced by electrostatic repulsion between
the negatively charged supporting layer and the negatively
charged compound. This enhanced electrostatic repulsion between
the ionised sulfamethoxazole and the FO membrane could lead to
the deformed sigmoidal rejection curve as observed in Fig. 6b. This
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Fig. 6. Rejection sulfamethoxazole and carbamazepine in (a) FO mode, (b) PRO
mode as a function of feed pH and (c) the speciation of sulfamethoxazole as a
function of pH. The data points represented the rejection at the end of 10-h
experiments (experimental conditions were as per Fig. 4).

observed enhanced rejection performance is also consistent with
the decreased speciﬁc salt ﬂux discussed in section 3.1.2.

4. Conclusion
In this study, we investigated the effects of membrane orientation and feed solution pH on permeate ﬂux and rejection of carbamazepine and sulfamethoxazole by an FO membrane. The
following conclusions could be drawn: (i) water ﬂux was pHdependent in both membrane orientations. An increase in water
ﬂux was observed with the increase of the feed solution pH, and
the speciﬁc reverse salt ﬂux and hydrogen ion ﬂux were hindered
in the basic pH range. These observations agreed well with the zeta
potential measurements of the FO membrane; (ii) the feed solution
pH induced different rejection behaviour for carbamazepine and
sulfamethoxazole. Rejection of the neutral carbamazepine compound was independent of pH, while rejection of sulfamethoxazole
was signiﬁcantly affected by pH as the speciation of sulfamethox-
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azole varied with pH; (iii) membrane orientation played an important role in both water ﬂux and PhACs rejection behaviour. Due to
concentrative and dilutive ICP effects, water ﬂux was higher in the
PRO mode than that with the FO mode. In the PRO mode, concentrative ICP in the porous supporting layer of the FO membrane resulted in a lower PhACs rejection value than that in the FO mode.
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